XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net income (loss) $ 511,711 $ (809,073)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 365,737 279,899
Inventory write-offs 50,000 0
Issuance of common stock for acquisition costs 0 127,500
Shares issued for services 175,000 0
Shares issued for finder fee 33,740 0
Bad debt expense 0 1,165
Loss on sale of equipment 0 6,292
Gain on forgiveness of SBA PPP loan (300,995) 0
Stock based compensation 593,098 93,193
Changes in assets and liabilities, net of acquiried amounts    
Accounts receivable 281,862 (257,858)
Inventory (426,955) (269,818)
Prepaid expenses and other assets (55,919) (30,231)
Change in deferred tax asset 151,322 0
Accounts payable and accrued liabilities (939,969) 21,225
Deferred revenue 378,725 200,521
Net cash provided by (used in) operating activities 817,357 (637,185)
Cash flows from investing activities    
Acquisition of VitaMedica (2,000,000) 0
Acquisition of Infusionz, Inc., net of cash acquired 0 212,122
Proceeds from sale of property and equipment 0 64,000
Acquisition of property and equipment (166,869) (5,454)
Net cash (used in) provided by investing activities (2,166,869) 270,668
Cash flows from financing activities    
Repayment of notes payable (150,000) (12,000)
Net cash used in financing activities (150,000) (12,000)
Net decrease in cash (1,499,512) (378,517)
Cash, beginning of period 14,534,211 887,517
Cash, end of period 13,034,699 509,000
Supplemental cash flow disclosures    
Interest paid 0 0
Income tax paid 0 0
Non-cash financing activities    
Issuance of common stock for acquisition of Infusionz 1,764,876 340,000
Issuance of common stock for acquisition of VitaMedica 482,000 0
Repayment of Infusionz LLC debt to Grove, Inc. 0 72,000
Issuance of debt for acquisition of VitaMedica 1,000,000 0
Liabilities assumed from acquisition of Infusionz 0 (680,480)
Liabilities assumed from acquisition of VitaMedica (309,574) 0
Stock issuance for payroll accrual $ 0 $ 0